Mariner Investment Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-60,500
Closed -$5.97M 147
2016
Q2
$5.97M Sell
60,500
-5,500
-8% -$569K 2.02% 15
2016
Q1
$6.61M Buy
66,000
+13,000
+25% +$1.34M 1.82% 9
2015
Q4
$6.35M Sell
53,000
-26,000
-33% -$3.01M 1.41% 13
2015
Q3
$8.54M Buy
79,000
+16,000
+25% +$1.99M 1.72% 11
2015
Q2
$7.29M Buy
63,000
+40,000
+174% +$4.57M 1.86% 6
2015
Q1
$2.65M Buy
23,000
+7,000
+44% +$836K 0.71% 46
2014
Q4
$1.79M Buy
16,000
+7,000
+78% +$738K 0.3% 87
2014
Q3
$853K Sell
9,000
-25,000
-74% -$2.26M 0.18% 114
2014
Q2
$2.92M Sell
34,000
-4,000
-11% -$304K 0.56% 49
2014
Q1
$2.65M Buy
+38,000
New +$3.01M 0.58% 39

Other funds holding CELG

Mariner Investment Group's CELG Position: Q3 2016 in Review

Mariner Investment Group sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 60,500 shares — an estimated $5.97M sold.

Mariner Investment Group first reported a position in CELG in Q1 2014 and held it in 10 quarters. The position peaked at $8.54M in Q3 2015. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Mariner Investment Group reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 60,500 Celgene Corp shares in Q3 2016, an estimated $5.97M.
  • Mariner Investment Group first reported a position in Celgene Corp in Q1 2014 and held it in 10 quarters.
  • Mariner Investment Group's Celgene Corp position peaked at $8.54M in Q3 2015.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.